|
Retuning the immune system in myelodysplastic syndromes: from immunomodulatory approaches to vaccination strategies and non myeloablative hemopoietic cell transplant.
|
Jan 2019
|
Crit Rev Oncol Hematol
|
myelodysplastic syndromes (MDS)
|
|
Prognostic value and clinical feature of SF3B1 mutations in myelodysplastic syndromes: A meta-analysis.
|
Jan 2019
|
Crit Rev Oncol Hematol
|
myelodysplastic syndromes (MDS)
|
|
Detection of paroxysmal nocturnal hemoglobinuria (PNH) in bone marrow aspirates
|
Jan 2019
|
Semin Hematol
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Effectiveness of eculizumab in patients with paroxysmal nocturnal hemoglobinuria (PNH) with or without aplastic anemia in the International PNH Registry
|
Jan 2019
|
Am J Hematol
|
aplastic anemia, paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Consider Allogeneic Bone Marrow Transplantation for Older, Fit Patients with Aplastic Anemia
|
Jan 2019
|
Biol Blood Marrow Transplant
|
aplastic anemia
|
|
TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups.
|
Jan 2019
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
|
Calculator-free point-of-care prognostication in myelodysplastic syndromes.
|
Jan 2019
|
Am J Hematol
|
myelodysplastic syndromes (MDS)
|
|
Treatment sequence of lenalidomide and hypomethylating agents and the impact on clinical outcomes for patients with myelodysplastic syndromes.
|
Jan 2019
|
Leuk Lymphoma.
|
myelodysplastic syndromes (MDS)
|
|
Mutation clonal burden and allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia and myelodysplastic syndromes.
|
Jan 2019
|
Bone Marrow Transplant
|
myelodysplastic syndromes (MDS)
|
|
Immunosuppressive therapy versus haploidentical transplantation in adults with acquired severe aplastic anemia
|
Jan 2019
|
Bone Marrow Transplant
|
aplastic anemia
|
